In bio-pharmaceutical field, bio-membrane is key material in the downstream process to produce a pharmaceutical The purpose of downstream processing is to purify and concentrate the synthesized drug substance with membrane.
According to ESG trend, Biotech companies are engaging in various activities to lessen the emission of plastics and pollution in recent years. 92% of response protested that ESG disclosures will be important and mandated. That would be related to economics and investment of the companies
One of the activities for this trend is MIT case in Boston. MIT is special place where 215 bio labs is forming bio-cluster. One start-up company collects plastic that is not directly used in experiments That can recycles 8,000 kilograms of plastics waste in a year.
So we design the innovate one of the biofilter product recyclable. We newly design bottle top filter to separate the bottle part where the biological hazards are concentrated, so that, they can be disposed separately. This is a way to reduce the plastic waste by more than 80% and secure this shape of linkage with patent not to be leak when it is used between the parts. Not only that, we also have the following technologies to produce/ eco-friendly filters in the manufacturing process. The solvent that are used In the recipe of production is safer than salt for the biological environment.